The life science instrumentation market is set to reach US$ 100,792.7 Mn by 2027 from US$ 57,185.5 Mn in 2018 showcasing moderate growth at a compounded annual growth rate (CAGR) of 6.5% during the forecast period from 2019 to 2027. Technological advancement in the life science instruments and stringent healthcare norms pertaining to food and drug manufacturing process drive the market growth for life science instrumentation techniques. Rising public health awareness and proactive government policies to curb the mortality associated with chronic diseases further propel the demand for life science instrumentation technology in the pharmaceutical and biotechnology companies.
The global genomics market held US$ 13,122.9 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 10.4% during the forecast period from 2018 to 2026. The exploration of genomics has surpassed in the last three decades to massive advancements in the technology that allowed the researchers to sequence larger pieces of genome.
The human microbiome market is set to reach US$ 1,990.5 Mn by 2026 from US$ 840.1 Mn in 2017 at a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2018 to 2026. According to the research findings of World Health Organization (WHO), the burden associated with non-communicable diseases is set increase to 57% by 2020.
The global bacteriophage market held US$ 567.9 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026. Bacteriophages are estimated as the most widely distributed and varied entities in the biosphere. From the initial research that defined the nature of viruses, bacteriophages have become model organisms for understanding the biochemistry.
The global tissue banking market is growing fruitfully, was valued at US$ 1,656.7 Mn in 2017 and expected to reach US$ 3,674.5 Mn by 2026. Worldwide growing cardiovascular procedures, utilization of advanced equipment types for excessive storage and preservation of human cells & tissues drives the overall market growth.
The oncology biosimilars market stood at US$ 1,651.5 Mn in 2017 and projected to exhibit a double-digit compound annual growth rate (CAGR) of 28.3% during the forecast period from 2018 to 2026. According to U.S. Food and Drug Administration, biosimilars are biological medicines that contain a highly similar version of the active substance of an already approved biologic, commonly referred to as the reference product.
Cell proliferation kits are assay based test solutions that aid in the quantification of cell proliferation and viability. Proliferation tests are based on the division of tetrazolium salt WST-1 to formazan by the activity of cellular mitochondrial dehydrogenases.
Plant-based meat protein is treated as an animal meat protein substitute which is mainly made of soy or gluten. It does not involve any animal product like meat or dairy. There are two methods by which plant-based meat products are processed: thermoplastic extrusion and fiber spinning.
Global biologics market accounted for market value of US$ 254.9 Bn in 2017 and expected to attain US$ 580.5 Bn by 2026. Recombinant therapeutic proteins contributed largest market share in 2017 while cellular and gene therapies exhibited fastest annual growth during the forecast period from 2018 to 2026.
Microscopy plays a central role in the field of life science in order to observe biological structure. It successfully allows to expand its usage in various domain of life science to get a magnified version of objects. The wide range of microscopy device varies in terms of degree of magnification, image resolution and the technology involved. The necessity of microscope is to gain a clear picture of biological structure in terms of diagnosis and treatment of any medical condition. Microscopy devices contributes significantly in the recent developments of drug discovery to cure diseases and to enhance quality of life.
Biotechnology Market Research Reports
Biotechnology is defined as the use of cell materials and living cells that conducts research and experiments to produce pharmaceutical and diagnostic items used in prevention and cure of human ailments. It is a one of the exceptionally rarest combination of cross-section disciplines that include biology, biochemistry, physics, genetic engineering, chemistry, biomedicine, microbiology, immunology, virology, biostatistics, botany, product reengineering, Pharmacology and material science.
Medical and scientific breakthroughs like environmental cleanup methods, microbial pesticides, disease resistant crops and insect resistant crops are introduced in the market due to medical biotechnology. A few most noticeable breakthroughs in this arena include discovery of insulin and growth hormone.
Pharmaceuticals biotechnology is a growing area of medical technology and medical sciences which contributes to supply of new beneficial drugs in the biotechnology market. Factors like growth of diagnostic agents for medical tests and gene therapy for altering the medical symptoms of inherited diseases are vital components of biotechnology.
Research experiments & trials carried out in biotechnology sector include stem cell research and human genome project. Stem cell therapy is the used to avoid or cure disease by using stem cells. Stem Cell therapy is used to regenerate the damages body exterior or interior parts and tissues. It is also used to cure dreaded diseases like cancer, Parkinson disease and Alzheimer disease. Human genome project helps in locating defective genes in the gene code sequence and disables their defective functionalities to get rid of the genetic diseases. Thus human genome project contributes towards annihilation of genetically transmitted diseases such as diabetes, hypertension and color blindness observed in our society.
The worldwide biotechnology sector is expected to earn revenue of more than $ 300 billion by the end of year 2015. Asian countries such as India and China are the most prominent as well as attractive markets of agronomic and industrialized biotechnology sector.
The biotechnology industry market reports segment of Acute Market Reports includes optimum information on the biopharmaceutical section primarily constituting of vaccines, branded remedial medications, generic pills, insulin and monoclonal antibodies. We have a vast collection of market research reports and analysis intended to make your search easy offering you with authentic information Our market research reports provides you ideal market research analysis of the biotechnology industry that will assist you in taking accurate business decisions contributing towards your business growth & expansion.
